Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis
June 22nd, 2021
3.3K views
This protocol describes the preparation of organotypic slice cultures (OTSCs). This technique facilitates the ex vivo cultivation of intact multicellular tissue. OTSCs can be used immediately to test for their respective response to drugs in a multicellular environment.
Overview
This protocol describes the preparation of organotypic slice cultures (OTSCs), which facilitate the ex vivo cultivation of intact multicellular tissue. OTSCs can be used immediately to test for their respective response to drugs in a multicellular environment.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Pharmacology
Background
- Organotypic tissue slices maintain tissue integrity.
- They model complex physiological mechanisms effectively.
- OTSCs from pancreatic carcinomas replicate tumor architecture ex vivo.
- They are suitable for drug response testing.
Purpose of Study
- To prepare organotypic slice cultures for research.
- To demonstrate the utility of OTSCs in drug testing.
- To provide a cost-effective alternative to primary culture techniques.
Methods Used
- Preparation of organotypic slice cultures from various tissues.
- Immediate culture after surgical resection.
- Assessment of drug responses in a multicellular environment.
- Demonstration of the procedure by a technical assistant.
Main Results
- OTSCs preserve the multicellular architecture of tissues.
- They are less time-consuming compared to traditional methods.
- OTSCs can be used for various downstream applications.
- Demonstrated effectiveness in modeling tumor microenvironments.
Conclusions
- OTSCs are a valuable tool for ex vivo research.
- They facilitate drug response testing in a relevant biological context.
- This method offers a practical approach to studying complex tissues.
Frequently Asked Questions
What are organotypic slice cultures?
Organotypic slice cultures are ex vivo models that maintain the architecture and cellular composition of tissues for research purposes.
How are OTSCs prepared?
OTSCs are prepared by slicing tissues and culturing them immediately after surgical resection.
What applications do OTSCs have?
OTSCs can be used for drug response testing and studying physiological mechanisms in a multicellular environment.
Who demonstrates the OTSC preparation procedure?
The procedure is demonstrated by Olha Lapshyna, a technical assistant from the University of Lubeck.
Why are OTSCs considered cost-effective?
OTSCs are less time-consuming and require fewer resources compared to traditional primary culture techniques.
What is the significance of preserving tissue integrity?
Preserving tissue integrity allows for more accurate modeling of physiological responses and interactions within the tissue.
Executive Industry Relevance
Organotypic slice cultures (OTSCs) provide a preclinical model that preserves the multicellular architecture and tumor microenvironment of primary pancreatic cancer and metastasis ex vivo. This enables spatially resolved drug response testing and individualized transcriptomic and proteomic profiling to support personalized treatment strategies. The approach addresses the critical need for predictive models that overcome limitations of cell line and xenograft systems lacking native stromal interactions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses within intact tumor-stroma interactions to clarify pathway dependencies and biological de-risking.
- Operational Value: Enables functional target validation using clinically relevant human tissue slices that maintain native microenvironmental cues.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream drug response testing with spatially resolved readouts.
- Operational Value: Supports assay standardization and reproducibility through consistent slice thickness and cultivation at air-liquid interface.
Translational & Preclinical Research
- Scientific Value: Links discovery to preclinical validation by enabling individual slice profiling for transcriptomic and proteomic biomarkers of drug response.
- Operational Value: Facilitates risk-adjusted advancement decisions by identifying heterogeneity in treatment response across slices from the same tumor.
Pipeline & Workflow Integration
OTSCs integrate into the discovery continuum from target validation through lead identification by providing a disease-relevant system for mechanistic de-risking and predictive confidence in drug efficacy.
- Discovery Biology: Supports hypothesis testing and pathway clarification by preserving multicellular architecture and stromal-tumor interactions ex vivo.
- Screening: Enables assay readiness and quantitative outputs via drug application to viable slices and subsequent analysis of viability, apoptosis, and molecular profiles.
- Analytics: Delivers measurements such as cleaved Caspase-3 staining, H&E histopathology, and transcriptome/proteome profiling to compare conditions and assess drug effects.
- Translational Research: Connects to preclinical continuity through individualized molecular profiling that aligns with potential biomarker-driven patient stratification.
- Enterprise Reuse: Establishes a reusable platform for ex vivo testing of multiple therapeutic regimes using tissue from surgical resection.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through preservation of tumor microenvironment and reduction of mechanistic ambiguity in drug response.
- Operational Value: Standardization, reproducibility, and scalability via vibratome-based sectioning and defined cultivation conditions.
- Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk by identifying non-responding slices early.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on slice-specific molecular and phenotypic responses.
Implementation Considerations
- Required scientific expertise in tissue handling, vibratome sectioning, and ex vivo culture techniques.
- Instrumentation and analytical infrastructure needs include low-melt agarose, vibratome, cell culture inserts, incubators, and downstream profiling tools (RNA sequencing, immunohistochemistry).
- Cross-team standardization requirements for slice thickness, cultivation medium, and viability assessment protocols.
- Adaptation considerations across model systems include variability in tumor stromal content and necrotic regions affecting slice viability.
- Practical limitations include gradual viability changes over culture period and potential loss of tumor cells in metastatic slices with low epithelial content, as observed in abdominal wall metastasis samples.
Biopharma FAQs
Why does viability assessment matter for OTSCs in target validation?
Viability assessment ensures that observed drug responses reflect biologically relevant conditions rather than artifacts from sectioning or culture stress, supporting reliable target validation.
How does isolating the tumor microenvironment as an independent variable improve discovery pipeline efficiency?
By maintaining native stromal-tumor interactions, OTSCs isolate the microenvironment as a key variable, enabling clearer interpretation of drug mechanism and reducing false positives in early screening.
What quantitative dependent variable measurements enable predictive confidence in drug response?
Measurements such as cleaved Caspase-3-positive cell counts, H&E histopathology scoring, and transcriptomic/proteomic profiles provide quantitative endpoints to correlate slice-specific drug effects with molecular changes.
Why do replication requirements across multiple slices matter for cross-functional collaboration?
Replication across slices from the same tumor captures intratumoral heterogeneity, ensuring that drug response conclusions are robust and translatable across biology, pharmacology, and clinical teams.
What statistical analysis capabilities are required before implementing OTSCs for drug screening?
Capabilities to analyze variance in viability, apoptosis, and molecular profiles across slices are needed to distinguish true drug effects from biological noise and support go/no-go decisions.
Chapters in this video
0:00
Introduction
0:54
Preparation of Low-Melting Agarose and Vibratome
1:58
Tissue Embedding in Low-Melting Agarose
3:13
Slicing of the Agarose-Embedded Tissue Using a Vibratome
3:51
Culture of Organotypic Slice Cultures
4:38
Formalin Fixation and Paraffin Embedding of OTSCs
6:20
Hematoxylin and Eosin Staining
7:09
Results: Morphology, Viability, and Histopathological Evaluation of the OTSCs at 6 and 15 Days of Primary PDAC and Metastasis
8:50
Conclusion
